AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma-Reference-Cited by-同舟云学术

AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma

Published:2023-11 Issue:11 Volume:36 Page:100303
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

Zheng Linmao^ORCID,Zhang Xingming,Pan Xiuyi,Huang Zhuo,Zhang Mengxin,Xian Jie,Wei Yuyan,Nie Ling,Zhang Mengni,Gong Jing,Chen Xueqin,Zhou Qiao,Zeng Hao^ORCID,Chen Ni^ORCID

Funder

National Natural Science Foundation of China

Sichuan Province Science and Technology Support Program

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference33 articles.

1. Urinary and male genital tumours,2022

2. Urinary and male genital tumours,2016

3. New developments in existing WHO entities and evolving molecular concepts: the genitourinary pathology society (GUPS) update on renal neoplasia;Trpkov;Mod Pathol,2021

4. Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases;Pan;J Clin Pathol,2019

5. A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients;Lau;Am J Surg Pathol,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma;Frontiers in Pharmacology;2024-06-21

2. Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase–Deficient Renal Cell Carcinoma;Clinical Cancer Research;2024-03-21

3. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma;Aging;2024-02-19

4. Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas;Advances in Anatomic Pathology;2023-12-25

5. AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway;Oncology Letters;2023-11-15